Lexicon Pharmaceuticals LXRX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Plus components not separately reported this period.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's total debt?
- Lexicon Pharmaceuticals (LXRX) reported total debt of $57.71M in Q1 2026.
- How has Lexicon Pharmaceuticals's total debt changed year-over-year?
- Lexicon Pharmaceuticals's total debt decreased by 45.7% year-over-year, from $106.26M to $57.71M.
- What is the long-term trend for Lexicon Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's total debt has grown at a 38.5% compound annual growth rate (CAGR), from $12.2M to $62.24M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.